Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

January 30, 2028

Conditions
Neonatal Sepsis
Interventions
DIAGNOSTIC_TEST

proclcitonin and presepsin

"All included patients will be subjected to:~* laboratory investigations~ * Complete Blood Count (CBC),~ * Liver Function Test(LFT) ( ALT,AST, Billirubin, total protein and albumin)~ * Kidney function test (KFT) ( Urea and creatinine)~ * Random Blood Glucose (RBG).~ * Erythrocyte Sedimentation Rate(ESR )~ * Urine analysis -A special investigations include (blood culture, C Reactive protein (CRP), proclcitonin and presepsin)."

Trial Locations (1)

Sohag

Sohag university Hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT06633770 - Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis | Biotech Hunter | Biotech Hunter